CA21116 – Identification of biological markers for prevention and translational medicine in pancreatic cancer
This Action aims at using innovative translational research to identify colorectal cancer biomarkers for personalized medicine that will improve screening, early detection and disease follow-up, and attain better tumor profiling, state-of-the-art functional characterization of genetic variants and new therapy approaches.
- Start of Action – 01/10/2018
- End of Action – 30/09/2022
- Participant: María José Serrano Fernández / Juan Sainz Pérez
- Group: A06-ONCOLOGIA RADIOTERAPICA / A20-GENETICA HEMOPATIAS MALIGNAS
Páginas web relacionadas: